LACHAPELLE ROBIN (Chief Operating Officer) exercised options at ARRIVENT BIOPHARMA, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
Common Stock
Shares
+2.05K
Price / share
$2.28
Trade value
$4.67K
% of position
Common Stock
Shares
+2.60K
Price / share
$2.28
Trade value
$5.93K
% of position
Common Stock
Shares
+6.50K
Price / share
$2.28
Trade value
$14.83K
% of position
Net shares
+11.15K
Net value
$25.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/11/2025 | M · Option Exercise | +2.05K | $2.28 | $4.67K | 1.6% | 124.58K | 126.63K |
| Common Stock Direct | 7/11/2025 | M · Option Exercise | +2.60K | $2.28 | $5.93K | 2.1% | 126.63K | 129.23K |
| Common Stock Direct | 7/11/2025 | M · Option Exercise | +6.50K | $2.28 | $14.83K | 5.0% | 129.23K | 135.74K |
| Total | +11.15K | $25.43K | ||||||
Stock Option (right to buy)
Common Stock
2.05K shares
Shares
−2.05K
Strike price
2.28
Held after
410.00
Exercisable
—
Stock Option (right to buy)
Common Stock
2.60K shares
Shares
−2.60K
Strike price
2.28
Held after
12.87K
Exercisable
—
Stock Option (right to buy)
Common Stock
6.50K shares
Shares
−6.50K
Strike price
2.28
Held after
6.37K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock2.05K shares | 7/11/2025 | M · Option Exercise | −2.05K | 2.28 | — | 410.00 |
| Stock Option (right to buy) Direct | Common Stock2.60K shares | 7/11/2025 | M · Option Exercise | −2.60K | 2.28 | — | 12.87K |
| Stock Option (right to buy) Direct | Common Stock6.50K shares | 7/11/2025 | M · Option Exercise | −6.50K | 2.28 | — | 6.37K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 394.48K | Indirect |
| Total | 394.48K | 394.48K indirect |